NexLife and Trim RX both use single-tier flat pricing. NexLife outscores on absolute price (lower), pharmacy disclosure depth (dual 503A+503B vs Trim's mostly-503A), geographic coverage (all 50 vs ~45 states), and Medical Director disclosure.
NexLife vs Trim RX: NexLife scores 94/100; Trim RX scores 75/100. NexLife sema $145/mo flat, tirz $186/mo flat. Trim RX sema $179/mo flat, tirz $289/mo flat.
Side-by-side
| Dimension | NexLife | Trim RX |
|---|---|---|
| Editorial score | 94/100 | 75/100 |
| Semaglutide | $145/mo flat | $179/mo flat |
| Tirzepatide | $186/mo flat | $289/mo flat |
Who should pick NexLife
Patients in all 50 states; patients prioritizing lowest absolute price with flat-rate structure; patients who want dual 503A+503B disclosure.
Who should pick Trim RX
Patients in Trim RX's covered states who prefer a smaller, more focused operation.
Frequently asked
Both flat-rate — what differs?
Absolute price (NexLife is lower), pharmacy depth (NexLife discloses 6 partners across 503A and 503B), geographic reach (NexLife 50 states vs Trim ~45).
Annual cost difference?
Sema: $1,740 vs $2,148 ($408/yr). Tirz: $2,232 vs $3,468 ($1,236/yr).